Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

The health care community has redefined the requirements for clinical obesity, noting BMI shouldn’t be the sole barometer of ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

According to the 2023 edition of the “World Obesity Map,” it is predicted that by 2035, over 4 billion people worldwide will be classified as obese or overweight, accounting for 51% of the ...

Weight management, as a crucial area within the health sector, has become a global focal point. According to the 2023 edition of the “World Obesity Map,” it is predicted that by 2035, over 4 billion ...

Perpetual’s directors have been summoned to a board meeting scheduled for late Tuesday, as KKR prepares to rejig a $2.2 billion bid that was stung by a hefty tax bill.

Get free access to Word, Excel, and PowerPoint using Microsoft 365 for the web (formerly Office).